A retrospective observational study

Abstract The present study aimed to investigate the predictive value of free fatty acid (FFA) in embolic stroke of undetermined source (ESUS) according to the presence of potential embolic sources (PES) after extensive etiologic evaluation. This was a retrospective observational study based on a single-center registry from January 2011 to July 2017. Stroke subtypes were determined through laboratory findings, brain, and angiographic imaging, carotid ultrasonography, transthoracic echocardiography, and 24-hour Holter monitoring. If ESUS was suspected, transesophageal echocardiography was additionally performed. Patients were classified into ESUS with PES and ESUS without PES. PES included mitral annular calcification, mitral valve prolapse, patent foramen ovale, atrial septal aneurysm, spontaneous echo contrast, ventricular aneurysm, and high-risk plaques of aortic arch, or carotid bulb. We compared clinical and laboratory findings between the two groups. Of a total of 110 ESUS patients, 61 patients (55.5%) had no PES. Patients with ESUS without PES had higher levels of serum FFA, systolic blood pressure, diastolic blood pressure (DBP), and left atrial (LA) enlargement compared with those of ESUS with PES. Multivariable analysis demonstrated that the FFA level, DBP, and LA volume index were associated with ESUS without PES [odds ratio (OR) 1.038, 95% confidence interval (CI) 1.019–1.058 for FFA/10 μEq/L, OR 1.414, 95% CI 1.037–1.928 for DBP/10 mm Hg, and OR 1.073, 95% CI 1.009–1.141 for LA volume index]. Higher levels of FFA, DBP, and LA volume index are associated with ESUS without PES, highlighting the need to identify the role of these markers in ESUS through further large-scale, multi-center and prospective studies.

[1]  R. Sacco,et al.  Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source , 2019, The New England journal of medicine.

[2]  A. Tuttolomondo,et al.  HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke , 2019, Journal of Neuroinflammation.

[3]  S. Rangaraju,et al.  Coagulation markers and echocardiography predict atrial fibrillation, malignancy or recurrent stroke after cryptogenic stroke , 2018, Medicine.

[4]  K. Cho,et al.  Epicardial Fat Thickness and Free Fatty Acid Level are Predictors of Acute Ischemic Stroke with Atrial Fibrillation , 2018, Journal of cardiovascular imaging.

[5]  S. Connolly,et al.  Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source , 2018, The New England journal of medicine.

[6]  J. Kim,et al.  Free Fatty Acid Is Associated with Thrombogenicity in Cardioembolic Stroke , 2017, Cerebrovascular Diseases.

[7]  G. D. de Borst,et al.  Diastolic Blood Pressure is a Risk Factor for Peri-procedural Stroke Following Carotid Endarterectomy in Asymptomatic Patients , 2017, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[8]  R. Mikolajczyk,et al.  Association between Embolic Stroke Patterns, ESUS Etiology, and New Diagnosis of Atrial Fibrillation: A Secondary Data Analysis of the Find-AF Trial , 2017, Stroke research and treatment.

[9]  Klaus Gröschel,et al.  Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AFRANDOMISED): an open-label randomised controlled trial , 2017, The Lancet Neurology.

[10]  T. Tegos,et al.  Imaging of the ulcerated carotid atherosclerotic plaque: a review of the literature , 2017, Insights into Imaging.

[11]  K. Kario,et al.  Higher Risk of Ischemic Events in Secondary Prevention for Patients With Persistent Than Those With Paroxysmal Atrial Fibrillation , 2016, Stroke.

[12]  A. Alexandrov,et al.  The value of transesophageal echocardiography for embolic strokes of undetermined source , 2016, Neurology.

[13]  J. Saver,et al.  CLINICAL PRACTICE. Cryptogenic Stroke. , 2016, The New England journal of medicine.

[14]  Jeong-Yoon Choi,et al.  Free fatty acid as an outcome predictor of atrial fibrillation–associated stroke , 2016, Annals of neurology.

[15]  R. Passman,et al.  Uncovering Atrial Fibrillation Beyond Short-Term Monitoring in Cryptogenic Stroke Patients: Three-Year Results From the Cryptogenic Stroke and Underlying Atrial Fibrillation Trial , 2016, Circulation. Arrhythmia and electrophysiology.

[16]  H. Kamel,et al.  Left Atrial Enlargement and Stroke Recurrence: The Northern Manhattan Stroke Study , 2015, Stroke.

[17]  C. Buttá,et al.  Peripheral Frequency of CD4+ CD28− Cells in Acute Ischemic Stroke , 2015, Medicine.

[18]  G. Breithardt,et al.  Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial , 2014, European heart journal.

[19]  Frank Beckers,et al.  Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.

[20]  S. Connolly,et al.  Embolic strokes of undetermined source: the case for a new clinical construct , 2014, The Lancet Neurology.

[21]  W. Tu,et al.  Prognostic Value of Plasma Neuroendocrine Biomarkers in Patients with Acute Ischaemic Stroke , 2013, Journal of neuroendocrinology.

[22]  B. Gersh,et al.  Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. , 2013, European heart journal.

[23]  Y. Kim,et al.  Elevated Free Fatty Acid is Associated with Cardioembolic Stroke Subtype , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[24]  P. Colonna,et al.  Recommendations for echocardiography use in the diagnosis and management of cardiac sources of embolism: European Association of Echocardiography (EAE) (a registered branch of the ESC). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[25]  W. März,et al.  Free fatty acids as a cardiovascular risk factor , 2008, Clinical chemistry and laboratory medicine.

[26]  K. Furie,et al.  An evidence‐based causative classification system for acute ischemic stroke , 2005, Annals of neurology.

[27]  A. Aljada,et al.  Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.

[28]  R. Sacco,et al.  Aortic atheromas and acute ischemic stroke , 1996, Neurology.

[29]  D. Kromhout Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts , 1995, The Lancet.

[30]  S. Vaziri,et al.  Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.

[31]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[32]  A. Weyman,et al.  Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. , 1990, Circulation.

[33]  Daniel B Hier,et al.  Infarcts of undetermined cause: The NINCDS stroke data bank , 1989, Annals of neurology.

[34]  A. A. Spector,et al.  Effect of Free Fatty Acids on ADP-induced Platelet Aggregation , 1970, Nature.

[35]  W. Connor,et al.  Massive thrombosis produced by fatty acid infusion. , 1963, The Journal of clinical investigation.

[36]  R. Grimm,et al.  Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism. , 2016, Journal of the American Society of Echocardiography.

[37]  M. Siddiqui,et al.  Spontaneous echo contrast in left atrial appendage during sinus rhythm. , 2001, Texas Heart Institute journal.